Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

CPRXCPRX
Showing 8 of 31 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in CATALYST PHARMACEUTICALS INC

RHUMBLINE ADVISERS holds 272,465 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $8.6M as of 2026-Q2. The position was decreased (-10.8% shares). CPRX represents 0.0% of RHUMBLINE ADVISERS's portfolio.

Current Value

$8.6M

Current Shares

272,465

Total Value Change

+$2.4M

Total Shares Change

-38,903

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
272,465
-10.8%
$8.6M0.0%$31.43
0
2026-Q1
Decreased
305,520
-2.5%
$7.6M0.0%$23.92
0
2025-Q4
Decreased
313,414
-5.1%
$7.3M0.0%$23.29
0
2025-Q3
Increased
330,302
+0.4%
$6.5M0.0%$19.55
27
2025-Q2
Increased
329,078
+6.0%
$7.1M0.0%$21.78
29
2025-Q1
Decreased
310,568
-0.6%
$7.5M0.0%$24.69
0
2024-Q4
Increased
312,320
+0.3%
$6.5M0.0%$21.07
27
2024-Q3
Decreased
311,368
-3.8%
$6.2M0.0%$19.56
0

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used